Key releases are ad hoc announcements pursuant to SIX Swiss Exchange Art. 53 LR
Latest press release
23 . 10 . 2026
Press release
Latest press releases and news stories
Go to news archive
Featured News Article
23/10/2026
Press release
Galderma’s Relfydess™ (relabotulinumtoxinA) receives approval in China for frown lines
22/10/2026
Press release
Galderma delivers net sales of 4.765 B USD in the first nine months, up 25.1% at constant currency year-on-year, and raises full-year net sales guidance
21/10/2026
Press release
AMWC Dubai 2026: Galderma reinforces its Injectable Aesthetics leadership
19/10/2026
News story
AMWC Dubai 2026: Galderma’s scientific presentations and activities
15/10/2026
Press release
PeDRA 2026: Nemolizumab phase II data show long-term symptom relief for children aged 2 to 11 years with moderate-to-severe atopic dermatitis
GALDERMA'S COMPREHENSIVE GUIDE TO SKIN QUALITY
Explore new insights and tools that can support people at every step of their skin quality journey.
GALDERMA'S RESPONSE TO AESTHETIC IMPACT OF MEDICATION-DRIVEN WEIGHT LOSS
Discover key insights from the first international consensus guidelines in the full report.
Galderma Annual Reports
MEDIA TOOLKIT: ATOPIC DERMATITIS
Access materials for additional information about the burden of atopic dermatitis.
MEDIA TOOLKIT: PRURIGO NODULARIS
Access materials for additional information about the burden of prurigo nodularis.
MEDIA TOOLKIT: SENSITIVE SKIN AND MODERN LIFESTYLES
Galderma’s scientific response to a growing dermatological challenge.
MEDIA TOOLKIT: MEDICATION-DRIVEN WEIGHT LOSS
Understanding the aesthetic impacts of significant and rapid weight loss.
GET IN TOUCH WITH
05.08.2026
Press release
